Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Efficacy of dupilumab for the treatment of severe skin disease in cytotoxic T lymphocyte antigen-4 insufficiency: A role of type 2 inflammation?
Arruda, L Karla; Cordeiro, Daniel L; Langer, Sarah S; Koenigham-Santos, Marcel; Calado, Rodrigo T; Dias, Marina M; Anhesini, Leonardo R; Oliveira, João Bosco; Grimbacher, Bodo; Ferriani, Mariana P L.
J Allergy Clin Immunol Glob ; 2(1): 114-117, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37780100

RESUMEN

We report on the successful treatment of a severe, recalcitrant dermatitis caused by CTLA-4 insufficiency with dupilumab, raising the possibility of a role of type 2 immunity in clinical conditions associated with CTLA-4 insufficiency.

ENVIAR RESULTADO:
Email
Exportar
Imprimir
RSS
XML
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA